Your browser doesn't support javascript.
loading
Outcomes of comprehensive lymphadenectomy for patients with advanced stage ovarian carcinoma and rare histologic sub-types.
Nasioudis, Dimitrios; Latif, Nawar A; Haggerty, Ashley F; Giuntoli Ii, Robert L; Kim, Sarah H; Ko, Emily M.
Afiliación
  • Nasioudis D; Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA dimitrios.nasioudis@uphs.upenn.edu.
  • Latif NA; Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Haggerty AF; Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Giuntoli Ii RL; Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Kim SH; Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Ko EM; Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Int J Gynecol Cancer ; 31(8): 1132-1136, 2021 08.
Article en En | MEDLINE | ID: mdl-34193526
ABSTRACT

OBJECTIVE:

To investigate the prognostic significance of comprehensive lymphadenectomy at the time of primary debulking surgery for patients with rare histologic sub-types of epithelial ovarian carcinoma and clinically advanced stage disease who underwent complete gross resection.

METHODS:

The National Cancer Database was accessed and patients diagnosed between January 2010 and December 2015 with stage III-IV clear cell, endometrioid, mucinous, and low-grade serous carcinoma who underwent primary debulking surgery and achieved complete gross resection were identified. Patients who did not undergo lymphadenectomy and those who underwent comprehensive lymphadenectomy (defined as at least 20 lymph nodes removed) were selected for further analysis. Overall survival was compared with the log-rank test and a Cox model was constructed to control for confounders.

RESULTS:

A total of 381 patients were identified; 133 (34.9%) patients underwent comprehensive lymphadenectomy while 248 (65.1%) patients did not. There were no differences between the two groups in terms of patient race, age, presence of co-morbidities, type of treatment facility, disease stage, histology, and extent of intra-abdominal disease (p>0.05). There was no difference in overall survival between patients who did and did not undergo comprehensive lymphadenectomy (p=0.42); median overall survival was 51.48 and 47.38 months, respectively. After controlling for patient age, race, insurance status, presence of co-morbidities, intra-abdominal tumor spread, stage and histology, performance of systematic lymphadenectomy was not associated with better survival (HR 0.96, 95% CI 0.69 to 1.35).

CONCLUSION:

Comprehensive lymphadenectomy is not associated with a survival benefit for patients with rare histologic sub-types of epithelial ovarian carcinoma and advanced stage disease who underwent primary debulking surgery and complete gross resection.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Escisión del Ganglio Linfático Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Escisión del Ganglio Linfático Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Int J Gynecol Cancer Asunto de la revista: GINECOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos